Abstract
Iloprost is well-known in protecting myocardial tissue in a number of ischemic conditions, as has been demonstrated by many authors [1–3]. Beneficial effects of prostacyclin in acute myocardial ischemia have been previously described [4]. The primary mode of action remains unclear, and therefore we investigated this matter by comparing several animal models and by using different types of drugs.
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
References
Schrör K, Ohlendorf R, Darius H (1981) Beneficial effects of a new carbacyclin derivative, ZK 36374, in acute myocardial ischemia. J Pharmacol Exp Ther 219: 243–249
Schrör K, Darius H, Matzky R, Ohlendorf R (1981) The anti-platelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374) - equipotent to PGI2 in vitro. Naunyn- Schmiedebergs Arch Pharmacol 316: 252–256
Coker SJ, Parratt JR (1983) Prostacyclin-antiarrhythmic or arrhythmogenic? Comparison of the effects of intravenous and intracoronary prostacyclin and ZK 36 374 during coronary artery occlusion and reperfusion in anesthetized greyhounds. J Cardiovasc Pharmacol 5: 557–567
Ogletree ML, Lefer AM, Smith JB, Nicolaou KC (1979) Studies on the protective effect of prostacyclin in acute myocardial ischemia. Eur J Pharmacol 56: 95–103
Arnold G, Thiemermann CH, Heymans L, Schrör K (1985) Morphological analysis of the Iloprost effects on reperfused ischemic myocardium. In: Schrör K (ed) Prostaglandins and other eicosanoids in the cardiovascular system. Karger, Basel, pp 254–258
Hearse DJ (1984) Critical distinctions in the modification of myocardial cell injury. In: Opie LH et al. (ed) Calcium antagonists and cardiovascular disease. Raven, New York, pp 129–145 (Perspectives in cardiovascular research, vol 9 )
de Langen CDJ, van Gilst WH, Wesseling H (1985) Sustained protection by Iloprost of the porcine heart in the acute and chronic phases of myocardial infarction. J Cardiovasc Pharmacol 7: 924–928
van Gilst WH, Terpstra JA, de Langen CDJ (1985) Ventricular arrhythmias and purine loss upon reperfusion of ischemic myocardium: comparison of ZK 36374 and Diltiazem. In: Schrör K (ed) Prostaglandins and other eicosanoids in the cardiovascular system. Karger, Basel, pp 207–212
van Gilst WH, Boonstra PW, Terpstra JA, Wildevuur ChRH, de Langen CDJ (1984) Effect of four different calcium antagonists on recovery of the isolated rat heart after 24 h of hypothermic cardiac arrest. Eur Heart J 5 (suppl 1): 143
van Gilst WH, Boonstra PW, Terpstra JA, Wildevuur ChRH, de Langen CDJ (1985) Improved recovery of cardiac function after 24 h of hypothermic arrest in the isolated rat heart: comparison of a prostacyclin analogue (ZK 36374) and a calcium entry blocker ( Diltiazem ). J Cardiovasc Pharmacol 7: 520–524
van Gilst WH, Boonstra PW, Terpstra JA, Wildevuur ChRH, de Langen CDJ (1983) Improved functional recovery of the isolated rat heart after 24 hours of hypothermic arrest with a stable prostacyclin analogue (ZK 36374). J Mol Cell Cardiol 15: 789–792
de Langen CDJ, Meijboom EJ, Kingma JH (1984) Heart rate-dependent atrioventricular nodal conduction and the effects of calcium channel blocking drugs: comparison of verapamil and nifedipine. J Cardiovasc Pharmacol 6: 267–272
Levine JH, Spear JF, Michelson EL, Wetstein L, de Langen CDJ, Moore EN (1986) Programmed electrical stimulation: is a sensitive but specific protocol feasible? New Trends in Arrhythmias 1: 1–10
Moore EN, Spear JF, Michelson EL (1981) Electrophysiologic studies in a canine model of chronic myocardial infarction. In: Harrison DC (ed) Cardiac arrhythmias, a decade of progress. Hall, Boston, pp 407–418
van Gilst WH, de Graeff PA, Kingma JH, de Langen CDJ, Wesseling H (in press) Effects of Diltiazem on ischemia- and reperfusion-induced myocardial injury in vitro and in vivo. J Mol Cell Cardiol
Gobel FL, Nordstrom LA, Nelson RR, Jorgenson CR, Wang Y (1978) The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. Circulation 57: 549–556
Hearse D, Humphrey S, Nayler WG, Slade A, Border D (1975) Ultrastructural damage associated with reoxigenation of the anoxic myocardium. J Mol Cell Cardiol 7: 315–324
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag, Berlin Heidelberg
About this paper
Cite this paper
de Langen, C.D.J., van Gilst, W.H. (1987). The Protective Mechanism of Iloprost in Several Models of Jeopardizing Ischemia in the Myocardium. In: Gryglewski, R.J., Stock, G. (eds) Prostacyclin and Its Stable Analogue Iloprost. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71499-3_22
Download citation
DOI: https://doi.org/10.1007/978-3-642-71499-3_22
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71501-3
Online ISBN: 978-3-642-71499-3
eBook Packages: Springer Book Archive